Literature DB >> 11853049

Iron deficiency anemia in HIV infection: immunologic and virologic response.

Yusuf E Afacan1, Muhammad S Hasan, Jackson A Omene.   

Abstract

We report the immunologic and virologic response of iron deficiency anemia in two cases of human immunodeficiency virus (HIV)-infected individuals. The findings of this report suggest that caution be exercised in prescribing iron supplements to HIV-infected patients. The treatment of iron deficiency anemia should be combined with antiretroviral agents in people living with HIV/AIDS to avoid adverse immunologic and virologic consequences.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11853049      PMCID： PMC2594130     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN： 0027-9684            Impact factor:   1.798


  12 in total

1.  Role of iron in the pathogenesis of Mycobacterium avium infection in mice.

Authors:  A M Dhople; M A Ibanez; T C Poirier
Journal:  Microbios       Date:  1996

2.  Iron overload alters innate and T helper cell responses to Candida albicans in mice.

Authors:  A Mencacci; E Cenci; J R Boelaert; P Bucci; P Mosci; C Fè d'Ostiani; F Bistoni; L Romani
Journal:  J Infect Dis       Date:  1997-06       Impact factor: 5.226

Review 3.  Single nutrients and immunity.

Authors:  W R Beisel
Journal:  Am J Clin Nutr       Date:  1982-02       Impact factor: 7.045

4.  Glutathione deficiency is associated with impaired survival in HIV disease.

Authors:  L A Herzenberg; S C De Rosa; J G Dubs; M Roederer; M T Anderson; S W Ela; S C Deresinski; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

5.  HIV/AIDS case histories: iron deficiency anemia and altered iron metabolism in HIV infection.

Authors:  J A Monroe; J H Godwin; T A Godwin
Journal:  AIDS Patient Care STDS       Date:  2000-12       Impact factor: 5.078

6.  Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation.

Authors:  H M Lederman; A Cohen; J W Lee; M H Freedman; E W Gelfand
Journal:  Blood       Date:  1984-09       Impact factor: 22.113

7.  The adverse effect of iron repletion on the course of certain infections.

Authors:  M J Murray; A B Murray; M B Murray; C J Murray
Journal:  Br Med J       Date:  1978-10-21

8.  Iron chelation decreases NF-kappa B and HIV type 1 activation due to oxidative stress.

Authors:  C Sappey; J R Boelaert; S Legrand-Poels; C Forceille; A Favier; J Piette
Journal:  AIDS Res Hum Retroviruses       Date:  1995-09       Impact factor: 2.205

9.  Iron chelators as therapeutic agents against Pneumocystis carinii.

Authors:  G A Weinberg
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

10.  Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans.

Authors:  T Igarashi; C R Brown; Y Endo; A Buckler-White; R Plishka; N Bischofberger; V Hirsch; M A Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205
View more
  3 in total

1.  A review of the use of blood and blood products in HIV-infected patients.

Authors:  Karin van den Berg; James van Hasselt; Evan Bloch; Robert Crookes; James Kelley; Jonathan Berger; Charlotte Ingram; Anel Dippenaar; Rajendra Thejpal; Neil Littleton; Tersia Elliz; Gary Reubenson; Mark Cotton; Jennifer C Hull; Pamela Moodley; Yasmin Goga; William Eldridge; Moosa Patel; Eric Hefer; Arthur Bird
Journal:  South Afr J HIV Med       Date:  2012-06-07       Impact factor: 2.744

2.  Endolysosome iron restricts Tat-mediated HIV-1 LTR transactivation by increasing HIV-1 Tat oligomerization and β-catenin expression.

Authors:  Nabab Khan; Peter W Halcrow; Leo K Lakpa; Mohd Rehan; Xuesong Chen; Jonathan D Geiger
Journal:  J Neurovirol       Date:  2021-09-22       Impact factor: 2.643

3.  Impaired Hematologic Status in Relation to Clinical Outcomes among HIV-Infected Adults from Uganda: A Prospective Cohort Study.

Authors:  Amara E Ezeamama; David Guwatudde; Alla Sikorskii; Edmond K Kabagambe; Raybun Spelts; Grace Vahey; Jenifer I Fenton; Wafaie W Fawzi
Journal:  Nutrients       Date:  2018-04-12       Impact factor: 5.717
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.